限制iBio内部人出售1 970万股的禁闭协议将于2025年11月18日到期,允许不受限制的交易。 A lock-up agreement restricting iBio insiders from selling 19.7 million shares expires on Nov. 18, 2025, allowing unrestricted trading.

限制iBio公司执行董事和董事出售1 970万股和相关证券的封锁协议于2025年11月18日到期。 A lock-up agreement restricting iBio, Inc. executives and directors from selling 19.7 million shares and related securities expires on November 18, 2025. 2025年8月19日开始的90至91天限制要求作为承保人代表的Leerink Partners LLC事先征得其同意,以防止在公开报价后市场波动。 The 90- to 91-day restriction, which began August 19, 2025, required prior consent from Leerink Partners LLC, acting as underwriter representative, to prevent market volatility after a public offering. 该协议适用于特定股票期权,受限制股票单位和内部人士持有的股票券. The agreement applied to specific stock options, restricted stock units, and warrants held by insiders. 期满时,这些内幕人士可根据正常证券条例自由交易其股份。 Upon expiration, these insiders may freely trade their shares under normal securities regulations.